Fresh from a decision by the Center for Medicare Services to establish national pricing for its VENDAJE allografts for regenerative therapies, BioStem Technologies (OTCQB:BSEM) is gearing up for a new spurt of growth.
Follow link to read more: BioStem Technologies harnessing perinatal tissue for regenerative therapies - BioTuesdays